Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Serbia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20114
20121
20151
20162
20173
20183
20191
20204
20211
20221
20231
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated10
Active, not recruiting3
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Eli Lilly and Company3
Pfizer3
Theravance Biopharma3
InDex Pharmaceuticals2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Protagonist Therapeutics, Inc.2
Spyre Therapeutics, Inc.2
Arena Pharmaceuticals1
GB004, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases30
Colitis, Ulcerative20
Colitis9
Crohn Disease7
Gastrointestinal Diseases5
Colonic Diseases2
Digestive System Diseases2
Intestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.